Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-794 in healthy volunteers and influenza challenge
NCT02588521Phase 1Completed
- Sponsor
- Alios BioPharma
- Start
- Aug 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in influenza comparing AL-794 with Placebo (2 arms). Primary endpoint: Safety Data including adverse events, physical exam, vital signs, ECGs, lab results at Day 28. Started Aug 2015; status: completed.
02
Drugs
AL-794
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02588521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02588521.